Oscillating Positive Expiratory Pressure Devices Market Global Report 2028

Oscillating Positive Expiratory Pressure (OPEP) Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Mouthpiece PEP Devices, Face Mask PEP Devices, and Bottle PEP Devices), Indication [Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchitis, Bronchiectasis, Cystic Fibrosis, and Others], and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies)

  • Report Code : TIPRE00015230
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 175

Oscillating Positive Expiratory Pressure Devices Market Global Report 2028

Buy Now

The oscillating positive expiratory pressure (OPEP) devices market is projected to grow from US$ 125.66 million in 2021 to US$ 179.34 million by 2028; it is estimated to grow at a CAGR of 5.2% during 2021–2028.

Oscillatory positive expiratory pressure (OPEP) devices have been in use as a supplement to traditional chest physiotherapy (CPT) to aid the clearing of respiratory secretions in people who can't cough, especially those with chronic conditions. The use of OPEP devices is still limited in chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices help with sputum clearance.

The oscillating positive expiratory pressure (OPEP) devices market growth is attributed to the growing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and advancements in medical technologies. However, low awareness and limited access to OPEP devices hinder the growth of the market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Oscillating Positive Expiratory Pressure (OPEP) Devices Market: Strategic Insights

Oscillating Positive Expiratory Pressure (OPEP) Devices Market
  • CAGR
    CAGR (2021 - 2028)
    5.2%
  • Market Size 2021
    US$ 125.66 Million
  • Market Size 2028
    US$ 179.34 Million

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Allergan Plc
  • PARI GmbH
  • Smiths Medical
  • AirPhysio
  • D R BURTON HEALTHCARE
  • Medica Holdings LLC
  • CEGLA Medizintechnik GmbH Co KG
  • Able Healthcare
  • Trudell Medical International

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market SegmentProduct
  • Mouthpiece PEP Devices
  • Face Mask PEP Devices
  • Bottle PEP Devices
Market SegmentIndication
  • Chronic Obstructive Pulmonary Disease
Market SegmentAsthma, Bronchitis, Bronchiectasis, Cystic Fibrosis, and Others)
    Market SegmentDistribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Market Insights
    Growing Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Asthma Boosts Market Growth

    The incidence of COPD and cystic fibrosis is rising across the world. According to the World Health Organization (WHO), COPD exacerbations are critical events. COPD-related disability and mortality propel the demand for OPEP devices. According to the Center for Disease Control and Prevention (CDC), ~9 million adults were diagnosed with chronic bronchitis in 2018. Also, asthma is becoming common among people of all ages, genders, and races. According to CDC, ~300 million people worldwide suffer from asthma, with the expected addition of 100 million by 2025. The prevalence, severity, and mortality of asthma vary dramatically across the US. Asthma affects more than 25 million people in the US, which equates to 7.7% of adults and 8.4% of children. According to the 2018 Global Asthma Report about Auckland, New Zealand, asthma ranks 16th among the largest causes of disability and 28th among the greatest sources of disease burden, as assessed by disability-adjusted life years. It is common in high-income countries, whereas the majority of asthma-related deaths occur in low- and middle-income countries. Therefore, the rising prevalence of COPD and asthma propels the demand for mucous clearing devices, such as OPEP devices, which bolsters the growth of the oscillating positive expiratory pressure (OPEP) devices market.

    Product-Based Insights

    The oscillating positive expiratory pressure (OPEP) devices market, based on product, is segmented into mouthpiece PEP devices, face mask PEP devices, and bottle PEP devices. The mouthpiece PEP devices segment held the largest share of the market in 2021. Moreover, it is anticipated to register a CAGR of 5.3% in the market during the forecast period. Mouthpiece PEP helps to remove mucus from the lungs. It can also prevent lung collapse or open up areas that have collapsed. One of the key factors driving the market for mouthpiece PEP devices is the growing elderly population, coupled with higher rates of chronic illnesses such as chronic obstructive pulmonary disease (COPD) and asthma. According to the Centers for Disease Control and Prevention (CDC), ~9 million persons will be diagnosed with chronic bronchitis by 2020, thereby driving the need for mouthpiece devices.

    Indication Insights

    Based on indication, the oscillating positive expiratory pressure (OPEP) devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, bronchitis, bronchiectasis, cystic fibrosis, and others. The COPD segment held the largest share of the market in 2021. However, the asthma segment is anticipated to register a CAGR of 6.0% during the forecast period. COPD is a common and treatable disease characterized by progressive airflow limitation and tissue destruction. It is associated with structural lung changes due to chronic inflammation from prolonged exposure to noxious particles or gases, most commonly cigarette smoke. Chronic inflammation causes airway narrowing and decreased lung recoil.

    Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the oscillating positive expiratory pressure (OPEP) devices market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally. The market is anticipated to flourish in the coming years due to the development of innovative products by market players.

    Oscillating Positive Expiratory Pressure Devices Market Report Scope

    Report Attribute Details
    Market size in 2021 US$ 125.66 Million
    Market Size by 2028 US$ 179.34 Million
    Global CAGR (2021 - 2028) 5.2%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By Product
    • Mouthpiece PEP Devices
    • Face Mask PEP Devices
    • Bottle PEP Devices
    By Indication
    • Chronic Obstructive Pulmonary Disease
    By Asthma, Bronchitis, Bronchiectasis, Cystic Fibrosis, and Others)
      By Distribution Channel
      • Hospital Pharmacies
      • Online Pharmacies
      • Retail Pharmacies
      Regions and Countries Covered North America
      • US
      • Canada
      • Mexico
      Europe
      • UK
      • Germany
      • France
      • Russia
      • Italy
      • Rest of Europe
      Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Rest of Asia-Pacific
      South and Central America
      • Brazil
      • Argentina
      • Rest of South and Central America
      Middle East and Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of Middle East and Africa
      Market leaders and key company profiles
      • Allergan Plc
      • PARI GmbH
      • Smiths Medical
      • AirPhysio
      • D R BURTON HEALTHCARE
      • Medica Holdings LLC
      • CEGLA Medizintechnik GmbH Co KG
      • Able Healthcare
      • Trudell Medical International
      • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

      Company Profiles

      • Allergan Plc.           
      • PARI GmbH             
      • Smith’s Medical      
      • AirPhysio                 
      • D•R BURTON HEALTHCARE               
      • Medica Holdings, LLC          
      • CEGLA Medizintechnik GmbH & Co. KG         
      • Able Healthcare     
      • Trudell Medical International            
      • Mercury Medical
      Report Coverage

      Report Coverage

      Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

      Segment Covered

      Segment Covered

      Product, Indication, and Distribution Channel

      Regional Scope

      Regional Scope

      North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

      Country Scope

      Country Scope

      Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, U.K, UAE, US

      Frequently Asked Questions


      What is the COVID 19 impact on the oscillating positive expiratory pressure (OPEP) devices market in the coming years?

      COVID-19 was more likely to hospitalize those with moderate-to-severe or uncontrolled asthma. The coronavirus can cause pneumonia, blood clots, and acute respiratory distress syndrome, among other lung issues. The epidemic has added new levels of anxiety for both patients and clinicians for the nearly 37 million Americans who live with a chronic lung illness like asthma or chronic obstructive pulmonary disease. Caring for people with COVID-19 and underlying COPD is very difficult at this time. Certain treatments for COPD patients, such as nebulized bronchodilators and non-invasive ventilation (NIV), are thought to enhance the risk of viral transmission via aerosols. Although oscillating positive expiratory pressure (OPEP) devices have been in use with the increasing cases of COVID-19 in the region as studies shows oscillating positive expiratory pressure (OPEP) devices results in minimizing the effect of respiratory distress due to COVID. Also, the Positive Expiratory Pressure (PEP) flute therapy and Positive End-Expiratory Pressure (PEEP) proved to be led to a small yet statistically significant decrease in the severity of respiratory symptoms in adults with COVID-19 recovering at home as per various research studies.

      Which region is expected to witness significant demand for the oscillating positive expiratory pressure (OPEP) devices market in the coming years?

      North America held the largest share of the oscillating positive expiratory pressure (OPEP) devices market and is expected to continue its position over the coming years. These oscillating positive expiratory pressure (OPEP) devices are in high demand in North America's regional segment. Furthermore, the presence of a robust medical infrastructure and the early availability of new products and equipment are aiding the area market's overall development.

      Which are the top companies that hold the market share in oscillating positive expiratory pressure (OPEP) devices market?

      Trudell Medical International and Allergan Plc are the top two companies that hold huge market shares in the Oscillating Positive Expiratory Pressure (OPEP) Devices market.

      Who are the key players in the oscillating positive expiratory pressure (OPEP) devices market?

      The Oscillating Positive Expiratory Pressure (OPEP) Devices market majorly consists of players such as Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; D•R BURTON HEALTHCARE; Medica Holdings, LLC; CEGLA Medizintechnik GmbH & Co. KG; Able Healthcare; Trudell Medical International; Mercury Medical amongst others.

      Which distribution channel held the largest share in the oscillating positive expiratory pressure (OPEP) devices market?

      The hospital pharmacies segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 60.48% in 2021.

      Which product led the oscillating positive expiratory pressure (OPEP) devices market?

      The mouthpiece PEP devices segment held the largest share of the market in the global oscillating positive expiratory pressure (OPEP) devices market and held the largest market share of 94.68% in 2021.

      Which indication held the largest share in the oscillating positive expiratory pressure (OPEP) devices market?

      The chronic obstructive pulmonary disease (COPD) segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 34.60% in 2021.

      What are oscillating positive expiratory pressure (OPEP) devices?

      Oscillatory positive expiratory pressure (OPEP) devices have been used as a supplement to traditional chest physiotherapy (CPT) to aid in the clearing of respiratory secretions in people who can't cough, especially those with chronic conditions. In chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome, the usage of OPEP devices is still limited. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices are said to help with sputum clearance.

      What are the driving factors for the oscillating positive expiratory pressure (OPEP) devices market across the globe?

      Key factors that are driving the growth of this market are the growing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and rising technological advancements are expected to boost the market growth for oscillating positive expiratory pressure (OPEP) devices over the years.

      What is the market CAGR value of the oscillating positive expiratory pressure (OPEP) devices market during the forecast period?

      The CAGR value of the oscillating positive expiratory pressure (OPEP) devices market during the forecasted period of 2021–2028 is 5.2%.

      The List of Companies - Oscillating Positive Expiratory Pressure (OPEP) Devices Market

      1. Allergan Plc.
      2. PARI GmbH
      3. Smiths Medical
      4. AirPhysio
      5. D•R BURTON HEALTHCARE
      6. Medica Holdings, LLC
      7. CEGLA Medizintechnik GmbH & Co. KG
      8. Able Healthcare
      9. Trudell Medical International
      10. Mercury Medical

      Trends and growth analysis reports related to Medical Device : READ MORE..